Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency

International Immunopharmacology

Volumn 4, Issue 6, 2004, Pages 745-753

  De Gracia, Javier ^a   Vendrell, Montserrat ^b   Álvarez, Antonio ^a   Pallisa, Esther ^a   Rodrigo, Maria José ^a   De La Rosa, David ^a   Mata, Fernando ^a   Andreu, Jordi ^a   Morell, Ferran ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

alanine transferase; ALT; Antibody deficiency; chronic pulmonary disease; Common variable immunodeficiency; common variable immunodeficiency; CPD; CVID; FEV1; forced expiratory volume in 1 s; forced vital capacity; FVC; IgG deficiency; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LUNG FUNCTION TEST; LUNG INJURY; MALE; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; INFECTION; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; STREPTOCOCCUS PNEUMONIAE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2342634251     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.02.011     Document Type: Article

References (35)

1. Chapel H., Geha F. Primary immunodeficiency diseases: an update. Clin. Exp. Immunol. 132:2003;9-15
2. Busse P.J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 109:2002;1001-1004
3. Buckley R.H., Schiff R.I. The use of intravenous immune globulin in immunodeficiency diseases. N. Engl. J. Med. 325:1991;110-117
4. De Gracia J., Vendrell M., Guarner M.L., Vidal R., Miravitlles M., Mayordomo C., et al. Utilización de gammaglobulina humana en el tratamiento de la inmunodeficiencia común variable. The use of human gamma globulin in the treatment of common variable immunodeficiency Med. Clin. (Barc.). 104:1995;201-206
5. Pirofsky B. Intravenous immune globulin therapy in hypogammaglobulinaemia. A Review. Am. J. Med. 76(3A):1984;53-60
6. Pruzanski W., Sussman G., Dorian W., Van T., Ibañez D., Redelmeier D. Relationship of dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency. Inflammation. 20:1996;353-359
7. Ochs H.D., Fisher S.H., Wedgwood R.J., Wara D.W., Cowan M.J., Ammann A.J., et al. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency disease. Am. J. Med. 76(3A):1984;78-82
8. Bernatowska E., Madalinski K., Janowicz W., Weremowicz R., Gutkowski P., Wolf H.M., et al. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison with plasma treatment. Clin. Immunol. Immunopathol. 43:1987;153-162
9. Eijkhout H.W., van der Meer J.W.M., Kallenberg C.G.M., Weening R.S., van Dissel J.T., Sanders L.A.M., et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomised, double-blind, multicenter crossover trial. Ann. Intern. Med. 135:2001;165-174
10. Roifman C.M., Levison H., Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1(8541):1987;1075-1077
11. Availability of immune globulin intravenous for treatment of immune deficient patients - United States, 1997-1998. MMWR. 48:1999;159-162
12. Kainulainen L., Varpula M., Liippo K., Svedstrom E., Nikoskelainen J., Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J. Allergy Clin. Immunol. 104:1999;1031-1036
13. Manson D., Reid B., Dalal I., Roifman C.M. Clinical utility of high-resolution pulmonary computed tomography in children with antibody deficiency disorders. Pediatr. Radiol. 27:1997;794-798
14. EMEA. Core SPC for human normal immunoglobulin for intravenous administration (IVIg). CPMP/BPWG/859/95 rev.1, 2000.
15. Rodrigo M.J., Vendrell M., Cruz M.J., Miravitlles M., Pascual C., Morell F., et al. Utility of the antibody response to conjugated Haemophilus influenzae Type B vaccine for diagnosis of primary humoral immunodeficiency. Am. J. Respir. Crit. Care Med. 162:2000;1462-1465
16. Rodrigo M.J., Miravitlles M., Cruz M.J., De Gracia J., Vendrell M., Pascual C., et al. Characterization of specific IgG and its subclases (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population. Proposal of a response criteria. Clin. Diagn. Lab. Immunol. 4:1997;168-172
17. Beam T.R. Jr., Gilbert D.N., Kunin C.M. General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15(Suppl. 1):1992;S5-S32
18. Roca J., Sanchís J.A., Agustí-Vidal A., Segarra F., Navajas D., Rodríguez-Roisin R., et al. Spirometric references values from a Mediterranean population. Bull. Eur. Physiopathol. Respir. 22:1986;217-224
19. Naidich D.P., McCauley D.I., Khouri N.F., Stitik F.P., Siegelman S.S. Computed tomography of bronchiectasis. J. Comput. Assist. Tomogr. 6:1982;437-444
20. Reid L. Reduction in bronchial subdivision in bronchiectasis. Thorax. 5:1950;233-247
21. Rodrigo M.J., Codina R., De Gracia J., Morell F., Pascual C. Valores normales de las subclases de la IgG en una población de adultos. Su importancia en el estudio de los déficits de las mismas. Normal values of the immunoglobulin G subclasses in an adult population. Importance in a study of their deficiency Med. Clin. (Barc.). 98:1992;166-170
22. Barker A.F. Bronchiectasis. N. Engl. J. Med. 346:2002;1383-1393
23. Hill A., Gompertz S., Stockley R. Factors influencing airway inflammation in chronic obstructive pulmonary disease. Thorax. 55:2000;970-977
24. Hansell D.M. Bronchiectasis. Radiol. Clin. North Am. 36:1998;107-128
25. Thompson A.B., Huerta G., Robbins R.A., Sisson J.H., Spurzem J.R., Von Essen S., et al. The bronchitis index. A semiquantitative visual scale for the assessment of airways inflammation. Chest. 103:1993;1482-1488
26. Loukides S., Horvath I., Wodehouse T., Cole P.J., Barnes P.J. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 158:1998;991-994
27. Munro N.C., Han L.Y., Curie D.C., Strickland B., Cole P.J. Radiological evidence of progression of bronchiectasis. Respir. Med. 86:1992;397-401
28. Thickett K.M., Kumararatne D.S., Banerjee A.K., Dudley R., Stableforth D.E. Common variable immune deficiency: respiratory, pulmonary function and high-resolution scan findings. QJM. 95:2002;655-662
29. Barker A.F., Couch L., Fiel S.B., Gotfried M.H., Ilowite J., Meyer K.C., et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am. J. Respir. Crit. Care Med. 162:2000;481-485
30. Ianaro A., Ialenti A., Maffia P., Sautebin L., Rombola L., Carnuccio R., et al. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 292:2000;156-163
31. Kolbe J., Wells A., Ram F.S. Inhaled steroids for bronchiectasis. Cochrane Database Syst. Rev. 2:2000;. [CD000996]
32. Llewellyn-Jones C.G., Johnson M.M., Mitchell J.L., Pye A., Okafor V.C., Hill S.L., et al. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion. Eur. Respir. J. 8:1995;1479-1487
33. Wills P., Greenstone M. Inhaled hyperosmolar agents for bronchiectasis (Cochrane Review). Cochrane Database Syst. Rev. 2:2001;. [CD002996]
34. Quartier P., Debré M., De Blic J., de Sauverzac R., Sayegh N., Jabado N., et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinaemia: a retrospective survey of 31 patients. J. Pediatr. 134:1999;589-596
35. Ballow M. Primary immunodeficiency disorders: antibody deficiency. J. Allergy Clin. Immunol. 109:2002;581-591